IP Library Granted Patent US 11,793,564
Granted Patent B2
US 11,793,564 · App. 18/161,725 · Granted Oct 24, 2023

Methods and systems for the treatment of polycystic ovary syndrome

Inventors: Denise Zarins (Saratoga, CA); Neil Barman (Menlo Park, CA); Garrett Schwab (Oakland, CA); Roger Osborne (La Honda, CA); Douglas Sutton (Pacifica, CA)
Assignee: May Health US Inc.
A61B18/1485A61B8/085A61B8/0841A61B8/12A61B18/1482A61F6/20A61B8/4427A61B8/4433A61B17/22004A61B17/42A61B18/06A61B18/1206A61B18/16A61B18/22A61B2017/003A61B2017/00278A61B2017/00455A61B2017/3405A61B2017/3413A61B2017/4233A61B2018/0072A61B2018/00196A61B2018/00273A61B2018/00285A61B2018/00291A61B2018/00559A61B2018/00577A61B2018/00589A61B2018/00595A61B2018/00642A61B2018/00702A61B2018/00726A61B2018/00732A61B2018/00744A61B2018/00767A61B2018/00791A61B2018/00875A61B2018/00982A61B2018/0293A61B2018/048A61B2018/143A61B2018/1432A61B2018/1475A61B2090/378A61B2090/3925A61B2090/3966A61N7/02A61N7/022A61N2007/0043
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,793,564
App. No.
18/161,725
Granted
Oct 24, 2023
Kind
B2
Abstract

Described here are methods and systems for the manipulation of ovarian tissues. The methods and systems may be used in the treatment of polycystic ovary syndrome (PCOS). The systems and methods may be useful in the treatment of infertility associated with PCOS.

Claims (25)

1. A method for treating infertility associated with polycystic ovary syndrome in a patient in need thereof, the method comprising:

advancing a docking device toward an ovary of the patient;

penetrating an ovarian wall of the ovary via a distal tip of the docking device;

advancing a therapeutic element from the docking device into the ovary; and

delivering energy into tissue from inside the ovary using the therapeutic element positioned inside the ovary to ablate a volume of the tissue ranging from 30 mm 3 to 3000 mm 3 within the ovary to treat infertility associated with polycystic ovary syndrome (PCOS).

2. The method of claim 1 , wherein penetrating the ovarian wall of the ovary comprises penetrating the ovarian wall at a single entry point.

3. The method of claim 1 , wherein delivering energy comprises delivering radiofrequency energy.

4. The method of claim 1 , wherein the tissue within the ovary comprises a polycystic ovary or ovarian cyst.

5. The method of claim 1 , wherein delivering energy into the tissue within the ovary comprises delivering energy for 20 to 60 seconds.

6. The method of claim 1 , wherein delivering energy into tissue reduces hormone levels to treat PCOS.

7. The method of claim 1 , wherein the volume of the tissue ablated is from a single ablation.

8. The method of claim 1 , wherein a total affected volume of the tissue ablated within the ovary is 240 mm 3 to 3000 mm 3 .

9. The method of claim 1 , wherein advancing the docking device comprises advancing the docking device into a vaginal canal, the method further comprising penetrating a vaginal wall via the distal tip of the docking device before penetrating the ovarian wall.

10. The method of claim 1 , wherein delivering energy comprises delivering direct heating, cryoablation, cooling, laser, microwave, unfocused ultrasound, partially-focused ultrasound element, focused (HIFU) ultrasound, heated water/saline, steam, or chemical ablation energy.

11. The method of claim 1 , further comprising imaging the ovary during an ablation procedure.

12. The method of claim 11 , wherein imaging the ovary comprises imaging the ovary via an ultrasound transducer in a field of view of the ultrasound transducer.

13. The method of claim 1 , further comprising, after delivering energy, reorienting the therapeutic element within the ovary, and then delivering additional energy within the ovary via the therapeutic element for one or more additional deliveries of energy within the ovary to ablate the tissue within the ovary.

14. The method of claim 1 , further comprising removably coupling the docking device to a handle of a transvaginal ultrasound probe via an adapter configured to be removably coupled to the handle of the transvaginal ultrasound probe.

15. The method of claim 1 , wherein the therapeutic element comprises an active electrode and a return electrode.

16. The method of claim 1 , further comprising measuring temperature at the electrode during an ablation procedure.

17. The method of claim 1 , further comprising measuring tissue temperature during an ablation procedure.

18. The method of claim 17 , further comprising automatically terminating energy delivery if the measured tissue temperature exceeds a predetermined threshold.

19. The method of claim 1 , further comprising measuring tissue impedance during an ablation procedure.

20. The method of claim 1 , wherein the therapeutic element forms a curved configuration upon deployment from a lumen of the docking device within the ovary.

21. The method of claim 1 , further comprising receiving user input comprising at least one of duration of energy emission, power, target temperature, or mode of operation.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2023
From: ZARINS, DENISE; BARMAN, NEAL; SCHWAB, GARRETT; OSBORNE, ROGER; SUTTON, DOUGLAS
To: ZIVA MEDICAL, INC.
Reel/Frame 062633/0781 →
CHANGE OF NAME Recorded Feb 8, 2023
From: ZIVA MEDICAL, INC.
To: ABLACARE, INC.
Reel/Frame 062687/0841 →
CHANGE OF NAME Recorded Feb 8, 2023
From: ABLACARE, INC.
To: MAY HEALTH US INC.
Reel/Frame 062687/0872 →
Continuity (8)
Continuation 17192870 · Mar 4, 2021
Continuation 16819022 · Mar 13, 2020
Division 15494188 · Apr 21, 2017
Continuation 15094852 · Apr 8, 2016
Continuation PCTUS2014061159 · Oct 17, 2014
Provisional Application 61969042 · Mar 21, 2014
Provisional Application 61892943 · Oct 18, 2013
Related Publication 20230233249A1 · Jul 27, 2023